Search

everythinglearnresearchcommunity

for

Search:↓

PRX102 is essential for rice root hair growth by helping transport substances to the tips.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Clinics using lasers should have trained laser safety supervisors to reduce accidents and possibly lower insurance costs.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

PRP injections improve hair thickness for baldness.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

The main cause of excessive hair growth in Turkish women is Polycystic ovary syndrome, but in about one fifth of cases, the reason for high male hormone levels is unknown.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

A patient had skin tissue death at the hair removal site after a hair transplant, which was treated with surgery.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.